These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 11760645)

  • 21. Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm.
    Karp BI; Alter K
    Semin Neurol; 2016 Feb; 36(1):84-91. PubMed ID: 26866500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blepharospasm and hemifacial spasm: a protocol for titration of botulinum toxin dose to the individual patient and for the management of refractory cases.
    Ortisi E; Henderson HW; Bunce C; Xing W; Collin JR
    Eye (Lond); 2006 Aug; 20(8):916-22. PubMed ID: 16531977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Botulinum toxin therapy for focal dystonia].
    Hahn K; Niklai E; Garzuly F; Szupera Z
    Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects.
    Dutton JJ
    Surv Ophthalmol; 1996; 41(1):51-65. PubMed ID: 8827930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experience with botulinum toxin treatment of facial-cervical dystonias and hemifacial spasm].
    Erbguth F; Claus D; Neundörfer B
    Nervenarzt; 1990 Oct; 61(10):611-4. PubMed ID: 2274093
    [No Abstract]   [Full Text] [Related]  

  • 26. [Botulinum toxin in the treatment of focal dystonias: own experience with botulinum toxin].
    Stefanoff P; Kiliszek M; Friedman A
    Neurol Neurochir Pol; 2000; 34(1):61-70. PubMed ID: 10849905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm.
    Chang LB; Tsai CP; Liao KK; Kao KP; Yuan CL; Yen DJ; Lin KP
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jan; 62(1):1-5. PubMed ID: 10063705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of movement disorders using botulinum toxin].
    Burgunder JM
    Schweiz Med Wochenschr; 1992 Sep; 122(36):1311-6. PubMed ID: 1411387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local treatment of dystonia and spasticity with injections of botulinum-A toxin.
    Calne S
    Axone; 1993 Jun; 14(4):85-8. PubMed ID: 8274387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm.
    Albanese A; Colosimo C; Carretta D; Dickmann A; Bentivoglio AR; Tonali P
    Eur Neurol; 1992; 32(2):112-7. PubMed ID: 1563461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections.
    Price J; Farish S; Taylor H; O'Day J
    Ophthalmology; 1997 May; 104(5):865-8. PubMed ID: 9160036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum A toxin therapy in ophthalmology: a report of patients with facial dystonias.
    Vissenberg I; Dieleman-Smet H; Tassignon MJ
    Bull Soc Belge Ophtalmol; 1993; 248():77-82. PubMed ID: 8044337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Blepharospasm: treatment with botulinum toxin].
    Barbosa ER; Silva HC; Haddad MS; Bittar MS
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(6):220-3. PubMed ID: 9239894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Applications of botulin].
    Lindberg L; Kanerva M; Pitkäranta A; Ansaranta M; Ylitalo L; Aaltonen LM; Pakarinen M; Salmenkylä S
    Duodecim; 2011; 127(22):2431-43. PubMed ID: 22238921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of facial spasm using botulinum toxin].
    Asanuma K; Kaji R
    No Shinkei Geka; 2003 May; 31(5):487-91. PubMed ID: 12755021
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical and psychological factors influencing the efficacy of botulinum toxin in the treatment of hemifacial spasm and blepharospasm].
    Burbaud P; Arnaud A; Burbaud A; Lagueny A
    J Fr Ophtalmol; 1995; 18(12):751-7. PubMed ID: 8745707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical application of botulinum toxin in otolaryngology, head and neck practice (brief review).
    Yin S; Stucker FJ; Nathan CO
    J La State Med Soc; 2001 Feb; 153(2):92-7. PubMed ID: 11261363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group.
    Berardelli A; Formica A; Mercuri B; Abbruzzese G; Agnoli A; Agostino R; Caraceni T; Carella F; De Fazio G; De Grandis D
    Ital J Neurol Sci; 1993 Jun; 14(5):361-7. PubMed ID: 8354632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consensus statement for the management of focal dystonias.
    Williams A
    Br J Hosp Med; 1993 Dec 15-1994 Jan 18; 50(11):655-9. PubMed ID: 8124547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.